Annual EBITDA
$48.99 M
+$12.07 M+32.68%
31 December 2023
Summary:
LeMaitre Vascular annual earnings before interest, taxes, depreciation & amortization is currently $48.99 million, with the most recent change of +$12.07 million (+32.68%) on 31 December 2023. During the last 3 years, it has risen by +$11.93 million (+32.19%). LMAT annual EBITDA is now at all-time high.LMAT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$13.15 M
-$3.62 M-21.57%
30 September 2024
Summary:
LeMaitre Vascular quarterly earnings before interest, taxes, depreciation & amortization is currently $13.15 million, with the most recent change of -$3.62 million (-21.57%) on 30 September 2024. Over the past year, it has increased by +$1.57 million (+13.59%). LMAT quarterly EBITDA is now -21.57% below its all-time high of $16.76 million, reached on 30 June 2024.LMAT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$59.09 M
+$1.57 M+2.73%
30 September 2024
Summary:
LeMaitre Vascular TTM earnings before interest, taxes, depreciation & amortization is currently $59.09 million, with the most recent change of +$1.57 million (+2.73%) on 30 September 2024. Over the past year, it has increased by +$18.22 million (+44.59%). LMAT TTM EBITDA is now at all-time high.LMAT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMAT EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +32.7% | +13.6% | +44.6% |
3 y3 years | +32.2% | +9.8% | +22.3% |
5 y5 years | +49.5% | +81.7% | +69.3% |
LMAT EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +32.7% | -21.6% | +93.1% | at high | +60.0% |
5 y | 5 years | at high | +80.8% | -21.6% | +126.0% | at high | +126.0% |
alltime | all time | at high | +3423.6% | -21.6% | +161.3% | at high | +388.4% |
LeMaitre Vascular EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $13.15 M(-21.6%) | $59.09 M(+2.7%) |
June 2024 | - | $16.76 M(+17.6%) | $57.52 M(+9.1%) |
Mar 2024 | - | $14.26 M(-4.5%) | $52.72 M(+7.6%) |
Dec 2023 | $48.99 M(+32.7%) | $14.93 M(+29.0%) | $48.99 M(+19.9%) |
Sept 2023 | - | $11.57 M(-3.2%) | $40.87 M(+8.2%) |
June 2023 | - | $11.96 M(+13.6%) | $37.77 M(+1.7%) |
Mar 2023 | - | $10.53 M(+54.6%) | $37.15 M(+0.6%) |
Dec 2022 | $36.92 M(-22.4%) | $6.81 M(-19.7%) | $36.92 M(-10.9%) |
Sept 2022 | - | $8.48 M(-25.2%) | $41.43 M(-7.8%) |
June 2022 | - | $11.34 M(+10.0%) | $44.93 M(-4.8%) |
Mar 2022 | - | $10.30 M(-9.0%) | $47.18 M(-0.8%) |
Dec 2021 | $47.58 M(+28.4%) | $11.31 M(-5.6%) | $47.58 M(-1.5%) |
Sept 2021 | - | $11.98 M(-11.8%) | $48.30 M(-1.5%) |
June 2021 | - | $13.59 M(+27.1%) | $49.05 M(+17.0%) |
Mar 2021 | - | $10.69 M(-11.2%) | $41.94 M(+13.2%) |
Dec 2020 | $37.06 M(+36.8%) | $12.04 M(-5.4%) | $37.06 M(+17.1%) |
Sept 2020 | - | $12.73 M(+96.6%) | $31.65 M(+21.0%) |
June 2020 | - | $6.47 M(+11.2%) | $26.15 M(-3.5%) |
Mar 2020 | - | $5.82 M(-12.2%) | $27.12 M(+0.4%) |
Dec 2019 | $27.09 M(-17.3%) | $6.63 M(-8.4%) | $27.02 M(-22.6%) |
Sept 2019 | - | $7.24 M(-2.7%) | $34.91 M(+4.9%) |
June 2019 | - | $7.43 M(+30.0%) | $33.29 M(+2.2%) |
Mar 2019 | - | $5.72 M(-60.6%) | $32.59 M(-0.5%) |
Dec 2018 | $32.77 M(+30.1%) | $14.52 M(+158.4%) | $32.77 M(+27.6%) |
Sept 2018 | - | $5.62 M(-16.5%) | $25.68 M(-1.7%) |
June 2018 | - | $6.73 M(+14.1%) | $26.12 M(+0.8%) |
Mar 2018 | - | $5.90 M(-20.7%) | $25.91 M(+2.9%) |
Dec 2017 | $25.18 M(+26.9%) | $7.43 M(+22.8%) | $25.18 M(+11.9%) |
Sept 2017 | - | $6.06 M(-7.1%) | $22.51 M(-0.6%) |
June 2017 | - | $6.52 M(+26.0%) | $22.64 M(+8.7%) |
Mar 2017 | - | $5.17 M(+8.6%) | $20.84 M(+5.2%) |
Dec 2016 | $19.85 M(+33.9%) | $4.76 M(-23.1%) | $19.81 M(+2.6%) |
Sept 2016 | - | $6.19 M(+31.3%) | $19.31 M(+14.2%) |
June 2016 | - | $4.71 M(+13.7%) | $16.90 M(+6.8%) |
Mar 2016 | - | $4.15 M(-2.6%) | $15.82 M(+6.8%) |
Dec 2015 | $14.82 M(+53.4%) | $4.26 M(+12.4%) | $14.82 M(+4.6%) |
Sept 2015 | - | $3.79 M(+4.2%) | $14.16 M(+8.2%) |
June 2015 | - | $3.63 M(+15.7%) | $13.09 M(+4.9%) |
Mar 2015 | - | $3.14 M(-12.8%) | $12.47 M(+20.7%) |
Dec 2014 | $9.66 M(+35.4%) | $3.60 M(+33.1%) | $10.33 M(+19.6%) |
Sept 2014 | - | $2.71 M(-10.3%) | $8.64 M(+16.0%) |
June 2014 | - | $3.02 M(+201.0%) | $7.45 M(+15.4%) |
Mar 2014 | - | $1.00 M(-47.5%) | $6.45 M(-9.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2013 | $7.13 M(+14.5%) | $1.91 M(+26.2%) | $7.13 M(+6.8%) |
Sept 2013 | - | $1.51 M(-25.2%) | $6.68 M(-1.0%) |
June 2013 | - | $2.02 M(+20.2%) | $6.75 M(+0.7%) |
Mar 2013 | - | $1.68 M(+15.6%) | $6.70 M(+7.6%) |
Dec 2012 | $6.23 M(+7.6%) | $1.46 M(-8.0%) | $6.23 M(+1.7%) |
Sept 2012 | - | $1.58 M(-19.9%) | $6.12 M(-12.6%) |
June 2012 | - | $1.98 M(+63.3%) | $7.00 M(-0.8%) |
Mar 2012 | - | $1.21 M(-10.5%) | $7.06 M(-4.2%) |
Dec 2011 | $5.79 M(+7.1%) | $1.35 M(-45.0%) | $7.37 M(+44.9%) |
Sept 2011 | - | $2.46 M(+20.9%) | $5.09 M(+1.7%) |
June 2011 | - | $2.04 M(+34.0%) | $5.00 M(-7.2%) |
Mar 2011 | - | $1.52 M(-263.2%) | $5.39 M(-2.4%) |
Dec 2010 | $5.41 M(+47.7%) | -$931.00 K(-139.1%) | $5.52 M(-32.2%) |
Sept 2010 | - | $2.38 M(-1.8%) | $8.14 M(+7.3%) |
June 2010 | - | $2.42 M(+46.8%) | $7.58 M(+14.0%) |
Mar 2010 | - | $1.65 M(-2.2%) | $6.65 M(+81.4%) |
Dec 2009 | $3.66 M(-413.6%) | $1.69 M(-7.5%) | $3.67 M(+118.3%) |
Sept 2009 | - | $1.82 M(+22.2%) | $1.68 M(+210.0%) |
June 2009 | - | $1.49 M(-211.8%) | $542.00 K(-156.0%) |
Mar 2009 | - | -$1.33 M(+343.2%) | -$967.00 K(-17.1%) |
Dec 2008 | -$1.17 M(-20.8%) | -$301.00 K(-143.9%) | -$1.17 M(-5.4%) |
Sept 2008 | - | $685.00 K(-4129.4%) | -$1.23 M(-43.7%) |
June 2008 | - | -$17.00 K(-98.9%) | -$2.19 M(-7.2%) |
Mar 2008 | - | -$1.53 M(+316.8%) | -$2.36 M(+60.3%) |
Dec 2007 | -$1.47 M(-266.4%) | -$368.00 K(+34.8%) | -$1.47 M(+23.9%) |
Sept 2007 | - | -$273.00 K(+46.8%) | -$1.19 M(+395.4%) |
June 2007 | - | -$186.00 K(-71.2%) | -$240.00 K(-62.7%) |
Mar 2007 | - | -$646.00 K(+669.0%) | -$643.00 K(-175.1%) |
Dec 2006 | $886.00 K(-66.3%) | -$84.00 K(-112.4%) | $856.00 K(-104.2%) |
Sept 2006 | - | $676.00 K(-214.8%) | -$20.49 M(+53.5%) |
June 2006 | - | -$589.00 K(-169.1%) | -$13.35 M(+155.3%) |
Mar 2006 | - | $853.00 K(-104.0%) | -$5.23 M(-468.2%) |
Dec 2005 | $2.63 M(+2.7%) | -$21.43 M(-374.1%) | $1.42 M(-70.4%) |
Sept 2005 | - | $7.82 M(+3.9%) | $4.80 M(+36.1%) |
June 2005 | - | $7.53 M(+0.4%) | $3.53 M(+38.6%) |
Mar 2005 | - | $7.50 M(-141.6%) | $2.55 M(+60.0%) |
Dec 2004 | $2.56 M(-87.6%) | -$18.05 M(-375.7%) | $1.59 M(-91.9%) |
Sept 2004 | - | $6.55 M(0.0%) | $19.64 M(+50.0%) |
June 2004 | - | $6.55 M(0.0%) | $13.09 M(+100.0%) |
Mar 2004 | - | $6.55 M | $6.55 M |
Dec 2003 | $20.66 M(+2380.7%) | - | - |
Dec 2002 | $833.00 K(-395.4%) | - | - |
Dec 2001 | -$282.00 K | - | - |
FAQ
- What is LeMaitre Vascular annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for LeMaitre Vascular?
- What is LeMaitre Vascular annual EBITDA year-on-year change?
- What is LeMaitre Vascular quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for LeMaitre Vascular?
- What is LeMaitre Vascular quarterly EBITDA year-on-year change?
- What is LeMaitre Vascular TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for LeMaitre Vascular?
- What is LeMaitre Vascular TTM EBITDA year-on-year change?
What is LeMaitre Vascular annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of LMAT is $48.99 M
What is the all time high annual EBITDA for LeMaitre Vascular?
LeMaitre Vascular all-time high annual earnings before interest, taxes, depreciation & amortization is $48.99 M
What is LeMaitre Vascular annual EBITDA year-on-year change?
Over the past year, LMAT annual earnings before interest, taxes, depreciation & amortization has changed by +$12.07 M (+32.68%)
What is LeMaitre Vascular quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of LMAT is $13.15 M
What is the all time high quarterly EBITDA for LeMaitre Vascular?
LeMaitre Vascular all-time high quarterly earnings before interest, taxes, depreciation & amortization is $16.76 M
What is LeMaitre Vascular quarterly EBITDA year-on-year change?
Over the past year, LMAT quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.57 M (+13.59%)
What is LeMaitre Vascular TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of LMAT is $59.09 M
What is the all time high TTM EBITDA for LeMaitre Vascular?
LeMaitre Vascular all-time high TTM earnings before interest, taxes, depreciation & amortization is $59.09 M
What is LeMaitre Vascular TTM EBITDA year-on-year change?
Over the past year, LMAT TTM earnings before interest, taxes, depreciation & amortization has changed by +$18.22 M (+44.59%)